Abstract:Abstract Lung cancer is one of the most common malignant tumors with high mortality worldwide. Recently, researchers reported that molecular markers on lung cancer could be used as diagnostic and prognostic targets. However, these molecules were not ideal in specificity and high selectivity. Therefore, exploring more reliable biomarkers to improve the prognosis and clarify the underlying mechanism is urgently needed both for clinic and basic research. This study aimed to identify significant genes with poor prediction for lung cancer and their underlying mechanisms. Firstly, we used gene expression datasets available from GEO (Gene Expression Omnibus) database. There were 109 lung cancer samples and 27 normal samples in the selected datasets. First, DEGs (Different Expressed Gene set) of lung cancer and normal lung samples were screen out with GEO2R tool, and we displayed them by Venn diagram software and Heatmap. Secondly, we used DAVID (Database for Annotation, Visualization and Integrated Discovery) to analyze KEGG (Kyoto Encyclopedia of Gene and Genome) pathway and GO (Gene Ontology). Third, PPI (Protein-Protein Interaction) of these DEGs was conducted by Cytoscape with STRING (Search Tool for the Retrieval of Interacting Genes). Our results showed that the expression trends of 21 up-regulated genes and 116 down-regulated were similar in selected three datasets. Analyzed by MCODE (Molecular Complex Detection) plug-in, 11 up-regulated and 16 down-regulated genes were selected. To further verify gene expression differences, GEPIA (Gene Expression Profiling Interactive Analysis) was implemented and we found 26 of 27 genes were found differently expressed in lung cancer compared with normal lung tissues. Furthermore, Kaplan–Meier analysis was used and we found 23 of 26 genes for overall survival indicated much less survival time. At last, three genes, CDH5, CLDN5, PECAM1, were found to be significantly decreased in lung cancer tissue proved through re-analysis of DAVID, which mainly co-related with leukocyte trans-endothelial migration. In conclusion, three significant down-regulated deferentially expressed genes with poor prognosis on lung cancer were identified basing on integrated bioinformatical methods. These down-expressed genes may be as a potential prognosis targets for patients with lung cancer.

Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis

An integrated bioinformatics approach to early diagnosis, prognosis and therapeutics of non-small-cell lung cancer

Survival-based Bioinformatics Analysis to Identify Hub Genes and Key Pathways in Non-Small Cell Lung Cancer

Identification and validation of key genes with prognostic value in non‐small‐cell lung cancer via integrated bioinformatics analysis

Identification of Key Genes in Non-Small Cell Lung Cancer by Bioinformatics Analysis

Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer

Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis

Identification of significant genes in non-small cell lung cancer by bioinformatics analyses

Identification of Genes and Analysis of Prognostic Values in Nonsmoking Females with Non-Small Cell Lung Carcinoma by Bioinformatics Analyses

Identification of Key Differentially Expressed Genes Associated with Non‑small Cell Lung Cancer by Bioinformatics Analyses.

Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis

Genes co-related with poor prognosis of patients with lung cancer via bioinformatical approaches

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis

Identification of key genes related to the mechanism and prognosis of lung squamous cell carcinoma using bioinformatics analysis